Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma

被引：0

作者：

Ganessan Kichenadasse

Jim Henry Hughes

John O. Miners

Arduino A. Mangoni

Andrew Rowland

Ashley M. Hopkins

Michael J. Sorich

机构：

[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health

[2] Flinders Medical Centre/Flinders University,Department of Medical Oncology, Flinders Centre for Innovation in Cancer

[3] University of South Australia,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2020年 / 85卷

关键词：

Vemurafenib; Melanoma; Threshold concentration; Survival;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：615 / 620

页数：5

共 50 条

[31] Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E [J].

Hallmeyer, Sigrun ;

Gonzalez, Rene ;

Lawson, David H. ;

Cranmer, Lee D. ;

Linette, Gerald P. ;

Puzanov, Igor ;

Taback, Bret ;

Cowey, C. Lance ;

Ribas, Antoni ;

Daniels, Gregory A. ;

Moore, Timothy ;

Gibney, Geoffrey T. ;

Tawbi, Hussein ;

Whitman, Eric ;

Lee, Geraldine ;

Mun, Yong ;

Liu, Shiyao ;

Hamid, Omid .

MELANOMA RESEARCH, 2017, 27 (06) :585-590

[32] Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib plus Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma [J].

Piejko, Karolina ;

Cybulska-Stopa, Bozena ;

Zietek, Marcin ;

Dziura, Robert ;

Galus, Lukasz ;

Kempa-Kaminska, Natasza ;

Ziolkowska, Barbara ;

Rutkowska, Ewa ;

Kopcinski, Tomasz ;

Kubiatowski, Tomasz ;

Bal, Wieslaw ;

Suwinski, Rafal ;

Mackiewicz, Jacek ;

Kaminska-Winciorek, Grazyna ;

Czarnecka, Anna M. ;

Rutkowski, Piotr .

TARGETED ONCOLOGY, 2023, 18 (02) :235-245

[33] Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019 [J].

Ugurel, Selma ;

Roehmel, Joachim ;

Ascierto, Paolo A. ;

Becker, Jurgen C. ;

Flaherty, Keith T. ;

Grob, Jean J. ;

Hauschild, Axel ;

Larkin, James ;

Livingstone, Elisabeth ;

Long, Georgina, V ;

Lorigan, Paul ;

McArthur, Grant A. ;

Ribas, Antoni ;

Robert, Caroline ;

Zimmer, Lisa ;

Schadendorf, Dirk ;

Garbe, Claus .

EUROPEAN JOURNAL OF CANCER, 2020, 130 :126-138

[34] Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry [J].

van Zeijl, M. C. T. ;

de Wreede, L. C. ;

van den Eertwegh, A. J. M. ;

Wouters, M. W. J. M. ;

Jochems, A. ;

Schouwenburg, M. G. ;

Aarts, M. J. B. ;

van Akkooi, A. C. J. ;

van den Berkmortel, F. W. P. J. ;

de Groot, J. W. B. ;

Hospers, G. A. P. ;

Kapiteijn, E. ;

Piersma, D. ;

van Rijn, R. S. ;

Suijkerbuijk, K. P. M. ;

Ten Tije, A. J. ;

van der Veldt, A. A. M. ;

Vreugdenhil, G. ;

van der Hoeven, J. J. M. ;

Haanen, J. B. A. G. .

EUROPEAN JOURNAL OF CANCER, 2021, 144 :242-251

[35] Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib [J].

Wongchenko, Matthew J. ;

Ribas, Antoni ;

Dreno, Brigitte ;

Ascierto, Paolo A. ;

McArthur, Grant A. ;

Gallo, Jorge D. ;

Rooney, Isabelle A. ;

Hsu, Jessie ;

Koeppen, Hartmut ;

Yan, Yibing ;

Larkin, James .

PIGMENT CELL & MELANOMA RESEARCH, 2018, 31 (04) :516-522

[36] Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes [J].

Schouwenburg, Maartje G. ;

Jochems, Anouk ;

Leeneman, Brenda ;

Franken, Margreet G. ;

van den Eertwegh, Alfons J. M. ;

Haanen, John B. A. G. ;

van Zeijl, Michiel C. T. ;

Aarts, Maureen J. ;

van Akkooi, Alexander C. J. ;

van den Berkmortel, Franchette W. P. J. ;

Blokx, Willeke A. M. ;

de Groot, Jan Willem B. ;

Hospers, Geke A. P. ;

Kapiteijn, Ellen ;

Koornstra, Rutger H. ;

Kruit, Wim H. ;

Louwman, Marieke W. J. ;

Piersma, Djura ;

van Rijn, Rozemarijn S. ;

Suijkerbuijk, Karijn P. M. ;

ten Tije, Albert J. ;

Vreugdenhil, Gerard ;

Wouters, Michel W. J. M. ;

van der Hoeven, Jacobus J. M. .

MELANOMA RESEARCH, 2018, 28 (04) :326-332

[37] Improved melanoma outcomes and survival in patients monitored by total body photography: A natural experiment [J].

Strunck, Jennifer L. ;

Smart, Tristan C. ;

Boucher, Kenneth M. ;

Secrest, Aaron M. ;

Grossman, Douglas .

JOURNAL OF DERMATOLOGY, 2020, 47 (04) :342-347

[38] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies [J].

Wu, Chiao-En ;

Yang, Chan-Keng ;

Peng, Meng-Ting ;

Huang, Pei-Wei ;

Chang, Ching-Fu ;

Yeh, Kun-Yun ;

Chen, Chun-Bing ;

Wang, Chih-Liang ;

Hsu, Chao-Wei ;

Chen, I-Wen ;

Lin, Cheng-Tao ;

Ueng, Shir-Hwa ;

Lin, Gigin ;

Lin, Yu-Fen ;

Cheng, Chi-Yuan ;

Chang, John Wen-Cheng .

BMC CANCER, 2020, 20 (01)

[39] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies [J].

Chiao-En Wu ;

Chan-Keng Yang ;

Meng-Ting Peng ;

Pei-Wei Huang ;

Ching-Fu Chang ;

Kun-Yun Yeh ;

Chun-Bing Chen ;

Chih-Liang Wang ;

Chao-Wei Hsu ;

I-Wen Chen ;

Cheng-Tao Lin ;

Shir-Hwa Ueng ;

Gigin Lin ;

Yu-Fen Lin ;

Chi-Yuan Cheng ;

John Wen-Cheng Chang .

BMC Cancer, 20

[40] Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600+MEK Inhibitors for Advanced Melanoma [J].

Lucas, Philippine ;

Boulinguez, Serge ;

Sibaud, Vincent ;

Mourey, Loic ;

Lamant, Laurence ;

Paul, Carle ;

Meyer, Nicolas .

DERMATOLOGY, 2018, 234 (3-4) :92-98

← 1 2 3 4 5 →